Contact this trialFirst, we need to learn more about you.
Tyrosine Kinase Inhibitor
Masitinib for Severe Mast Cell Activation Syndrome
Recruiting0 awardsPhase 2
Weldon Spring, Missouri
This trial tests if masitinib, a pill, can help people with severe MCAS who haven't improved with other treatments. It works by calming down cells that cause allergic reactions and inflammation.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service